title: Folic acid reverts dysfunction of endothelial nitric oxide synthase.
abstract: 5-methyltetrahydrofolate (MTHF), the active form of folic acid, has been reported to restore NO status in hypercholesterolemic patients. The mechanism of this effect remains to be established. We assessed the effects of L- and D-MTHF on tetrahydrobiopterin (BH(4))-free and partially BH(4)-repleted endothelial NO synthase (eNOS). Superoxide production of eNOS and the rate constants for trapping of superoxide by MTHF were determined with electron paramagnetic resonance using 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide (DEPMPO) as spin trap for superoxide. NO production was measured with [(3)H]arginine-citrulline conversion or nitrite assay. The rate constants for scavenging of superoxide by L- and D-MTHF were similar, 1.4 x 10(4) ms(-1). In BH(4)-free eNOS, L- and D-MTHF have no effect on enzymatic activity. In contrast, in partially BH(4)-repleted eNOS, we observe a 2-fold effect of MTHF on the enzymatic activity. First, superoxide production is reduced. Second, NO production is enhanced. In cultured endothelial cells, a similar enhancement of NO production is induced by MTHF. In the present study, we show direct effects of MTHF on the enzymatic activity of NO synthase both in recombinant eNOS as well as in cultured endothelial cells, which provides a plausible explanation for the previously reported positive effects of MTHF on NO status in vivo.
authors.affiliation: Department of Vascular Medicine, University Hospital Utrecht, The Netherlands. e.stroes@digd.azu.nl
authors.forename: E S
authors.initials: ES
authors.lastname: Stroes
authors.forename: E E
authors.initials: EE
authors.lastname: van Faassen
authors.forename: M
authors.initials: M
authors.lastname: Yo
authors.forename: P
authors.initials: P
authors.lastname: Martasek
authors.forename: P
authors.initials: P
authors.lastname: Boer
authors.forename: R
authors.initials: R
authors.lastname: Govers
authors.forename: T J
authors.initials: TJ
authors.lastname: Rabelink
mesh_terms: D002478:Cells, Cultured; D004578:Electron Spin Resonance Spectroscopy; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000201:enzymology* / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III; D011622:Pterins / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D013763:Tetrahydrofolates / Q000494:pharmacology*; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D011622:Pterins; D011994:Recombinant Proteins; D013763:Tetrahydrofolates; D013481:Superoxides; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D014969:Xanthine Oxidase; C005984:5-methyltetrahydrofolate